Novartis (NVSN) Stock Forecast & Price Target
NVSN Analyst Ratings
NVSN Stock 12 Month Forecast
Average Price Target
MXN 2,979.80▲(2.36% Upside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Thibault Boutherin | Morgan Stanley | MXN 2,911.37→MXN 3,042.01 | buy | 4.50%Upside | Reiterated | 10/28/26 | ||
| Sachin Jain | Bank of America Securities | ― | buy | ― | Reiterated | 10/27/26 | ||
| Rajesh Kumar | HSBC | MXN 2,295.50→MXN 2,538.12 | hold | -12.81%Downside | Upgraded | 09/10/26 | ||
| Steve Scala | TD Cowen | MXN 3,359.27 | hold | 15.40%Upside | Reiterated | 09/08/26 | ||
| Kerry Holford | Berenberg Bank | MXN 2,631.43→MXN 2,743.41 | hold | -5.76%Downside | Reiterated | 07/27/26 | ||
| Jasper Hellweg | Argus Research | MXN 3,172.65 | buy | 8.99%Upside | Reiterated | 07/24/26 | ||
 Unknown AnalystNot Ranked | Goldman Sachs | MXN 2,612.77→MXN 2,594.11 | sell | -10.89%Downside | Reiterated | 07/22/26 | ||
| Justin Smith | Bernstein | ― | hold | ― | Initiated | 03/19/26 | ||
| Emily Field | Barclays | ― | hold | ― | Upgraded | 01/06/26 | ||
| Richard Vosser | J.P. Morgan | ― | hold | ― | Reiterated | 11/20/25 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Thibault Boutherin | 10/28/26 | MXN 2,911.37→MXN 3,042.01 | buy | 4.50%Upside | Reiterated | Morgan Stanley | ||
| Sachin Jain | 10/27/26 | ― | buy | ― | Reiterated | Bank of America Securities | ||
| Rajesh Kumar | 09/10/26 | MXN 2,295.50→MXN 2,538.12 | hold | -12.81%Downside | Upgraded | HSBC | ||
| Steve Scala | 09/08/26 | MXN 3,359.27 | hold | 15.40%Upside | Reiterated | TD Cowen | ||
| Kerry Holford | 07/27/26 | MXN 2,631.43→MXN 2,743.41 | hold | -5.76%Downside | Reiterated | Berenberg Bank | ||
| Jasper Hellweg | 07/24/26 | MXN 3,172.65 | buy | 8.99%Upside | Reiterated | Argus Research | ||
| Unknown AnalystNot Ranked | 07/22/26 | MXN 2,612.77→MXN 2,594.11 | sell | -10.89%Downside | Reiterated | Goldman Sachs | ||
| Justin Smith | 03/19/26 | ― | hold | ― | Initiated | Bernstein | ||
| Emily Field | 01/06/26 | ― | hold | ― | Upgraded | Barclays | ||
| Richard Vosser | 11/20/25 | ― | hold | ― | Reiterated | J.P. Morgan |
Best Analysts Covering Novartis
Copying Thibault Boutherin's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +12.43% per trade.
Copying Thibault Boutherin's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +11.33% per trade.
Copying Thibault Boutherin's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +11.33% per trade.
NVSN Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 4 | 4 | 4 | 7 |
| Hold | 2 | 4 | 3 | 4 | 2 |
| Sell | 0 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 4 | 9 | 8 | 9 | 9 |
In the current month, NVSN has received 7 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. NVSN average Analyst price target in the past 3 months is 2,979.80.
NVSN Financial Forecast
NVSN Earnings Forecast
Next quarter’s earnings estimate for NVSN is MXN 41.80 with a range of MXN 39.61 to MXN 43.22. The previous quarter’s EPS was MXN 45.96. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
NVSN Sales Forecast
Next quarter’s sales forecast for NVSN is MXN 274.46B with a range of MXN 264.80B to MXN 284.72B. The previous quarter’s sales results were MXN 269.70B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
